Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou Zahr, Abdallah, Saad Aldin, Ehab, Komrokji, Rami S, Zeidan, Amer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278786/
https://www.ncbi.nlm.nih.gov/pubmed/25565910
http://dx.doi.org/10.2147/JBM.S50482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278786/
https://www.ncbi.nlm.nih.gov/pubmed/25565910
http://dx.doi.org/10.2147/JBM.S50482

Ejemplares similares